| Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy H Einsele, E Roosnek, N Rufer, C Sinzger, S Riegler, J Löffler, ... Blood, The Journal of the American Society of Hematology 99 (11), 3916-3922, 2002 | 902 | 2002 |
| Detection and identification of fungal pathogens in blood by using molecular probes H Einsele, H Hebart, G Roller, J Löffler, I Rothenhofer, CA Müller, ... Journal of Clinical Microbiology 35 (6), 1353-1360, 1997 | 781 | 1997 |
| Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation H Einsele, G Ehninger, H Hebart, KM Wittkowski, U Schuler, G Jahn, ... Blood, The Journal of the American Society of Hematology 86 (7), 2815-2820, 1995 | 540 | 1995 |
| Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturation SL Kelly, DC Lamb, DE Kelly, NJ Manning, J Loeffler, H Hebart, ... FEBS letters 400 (1), 80-82, 1997 | 442 | 1997 |
| Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system J Loeffler, N Henke, H Hebart, D Schmidt, L Hagmeyer, U Schumacher, ... Journal of clinical microbiology 38 (2), 586-590, 2000 | 379 | 2000 |
| Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies H Hebart, C Bollinger, P Fisch, J Sarfati, C Meisner, M Baur, J Loeffler, ... Blood, The Journal of the American Society of Hematology 100 (13), 4521-4528, 2002 | 339 | 2002 |
| Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants R Hehlmann, M Lauseker, S Saußele, M Pfirrmann, S Krause, HJ Kolb, ... Leukemia 31 (11), 2398-2406, 2017 | 312 | 2017 |
| Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome C Sinzger, K Schmidt, J Knapp, M Kahl, R Beck, J Waldman, H Hebart, ... Journal of General Virology 80 (11), 2867-2877, 1999 | 312 | 1999 |
| Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection H Einsele, H Hebart, C Kauffmann-Schneider, C Sinzger, G Jahn, P Bader, ... Bone marrow transplantation 25 (7), 757-763, 2000 | 284 | 2000 |
| Early Detection of Aspergillus Infection after Allogeneic Stem Cell Transplantation by Polymerase Chain Reaction Screening H Hebart, J Löffler, C Meisner, F Serey, D Schmidt, A Böhme, H Martin, ... The Journal of infectious diseases 181 (5), 1713-1719, 2000 | 273 | 2000 |
| Aspergillus fumigatus antigens activate innate immune cells via toll‐like receptors 2 and 4 S Braedel, M Radsak, H Einsele, JP Latgé, A Michan, J Loeffler, ... British journal of haematology 125 (3), 392-399, 2004 | 260 | 2004 |
| Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood J Löffler, H Hebart, U Schumacher, H Reitze, H Einsele Journal of clinical microbiology 35 (12), 3311-3312, 1997 | 237 | 1997 |
| Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus S Riegler, H Hebart, H Einsele, P Brossart, G Jahn, C Sinzger Journal of General Virology 81 (2), 393-399, 2000 | 224 | 2000 |
| Contaminations occurring in fungal PCR assays J Loeffler, H Hebart, R Bialek, L Hagmeyer, D Schmidt, FP Serey, ... Journal of clinical microbiology 37 (4), 1200-1202, 1999 | 216 | 1999 |
| Sensitive detection of human cytomegalovirus peptide–specific cytotoxic T-lymphocyte responses by interferon-γ–enzyme-linked immunospot assay and flow cytometry in healthy … H Hebart, S Daginik, S Stevanovic, U Grigoleit, A Dobler, M Baur, ... Blood, The Journal of the American Society of Hematology 99 (10), 3830-3837, 2002 | 210 | 2002 |
| Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease H Krause, H Hebart, G Jahn, CA Müller, H Einsele Bone marrow transplantation 19 (11), 1111-1116, 1997 | 205 | 1997 |
| Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains J Löffler, SL Kelly, H Hebart, U Schumacher, C Lass-Flörl, H Einsele FEMS microbiology letters 151 (2), 263-268, 1997 | 199 | 1997 |
| Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV S Saußele, MP Krauß, R Hehlmann, M Lauseker, U Proetel, L Kalmanti, ... Blood, The Journal of the American Society of Hematology 126 (1), 42-49, 2015 | 195 | 2015 |
| Clinical aspects of CMV infection after stem cell transplantation H Hebart, H Einsele Human immunology 65 (5), 432-436, 2004 | 181 | 2004 |
| Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia H Hebart, J Löffler, H Reitze, A Engel, U Schumacher, T Klingebiel, ... British journal of haematology 111 (2), 635-640, 2000 | 168 | 2000 |
